AR

Abhishek Radhakrishna Kini

Active Director Director DIN 08820174
DIN 08820174 First appointment Aug 2020 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Aug 2020
Shareholding value •••• Premium profile

About Abhishek Radhakrishna Kini

Data last updated:

Abhishek Radhakrishna Kini is a Director at Novo Tissue Bank And Research Centre Private Limited (since 2020), Director at Dr. Abhishek Kini (Opc) Private Limited (since 2022) and Director at Bom Ao Pharmacy Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Life Sciences, Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.04 Cr; the largest is Novo Tissue Bank And Research Centre Private Limited at ₹60.9 Lakh (FY 2024). Earlier, Abhishek Radhakrishna Kini was a Designated Partner at Innov8 India Healthcare Llp (from 2020).

DIN 08820174
Primary Designation Director
Industry Life Sciences
First Appointment 03 Aug 2020
Oldest Company Age 6 yrs
Largest company Novo Tissue Bank And Research Centre Private Limited · ₹60.9 Lakh (FY 2024)
Combined revenue ₹1.04 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20202020₹60.9 Lakh (FY 2024)Active
Director21 Oct 20222022₹43.4 Lakh (FY 2025)Active
Bom Ao Pharmacy Private Limited U47721MH2024PTC427709
Director25 Jun 20242024Active
Director21 Feb 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Aug 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Innov8 India Healthcare Llp
Dr. Abhishek Kini (Opc) Private Limited
Novo Tissue Bank And Research Centre Private Limited
Bom Ao Pharmacy Private Limited
Premium access

Shareholding and investment profile for Abhishek Radhakrishna Kini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Radhakrishna Kini

Abhishek Radhakrishna Kini currently holds 4 directorships: Novo Tissue Bank And Research Centre Private Limited (Director, since 01 Dec 2020, revenue ₹60.9 Lakh (FY 2024)); Dr. Abhishek Kini (Opc) Private Limited (Director, since 21 Oct 2022, revenue ₹43.4 Lakh (FY 2025)); Bom Ao Pharmacy Private Limited (Director, since 25 Jun 2024); Bom Advanced Orthopaedics Private Limited (Director, since 21 Feb 2024).

Abhishek Radhakrishna Kini was first appointed on 03 Aug 2020 as Designated Partner at Innov8 India Healthcare Llp. The most recent appointment on record is 25 Jun 2024 at Bom Ao Pharmacy Private Limited.

The 2 current companies of Abhishek Radhakrishna Kini that report revenue have a combined latest revenue of ₹1.04 Cr: Novo Tissue Bank And Research Centre Private Limited ₹60.9 Lakh (FY 2024); Dr. Abhishek Kini (Opc) Private Limited ₹43.4 Lakh (FY 2025).

Abhishek Radhakrishna Kini held 1 earlier board appointment: Innov8 India Healthcare Llp (Designated Partner, from 03 Aug 2020).

The current boards of Abhishek Radhakrishna Kini's companies include Arpit Chittaranjan Dave (Novo Tissue Bank And Research Centre Private Limited), Prasad Kashinath Bhagunde (Novo Tissue Bank And Research Centre Private Limited), Miten Rajendra Sheth (Bom Ao Pharmacy Private Limited), Pallavi Ankur Pandey (Bom Ao Pharmacy Private Limited), Rajendra Rameshchandra Chaturvedi (Bom Ao Pharmacy Private Limited), Saloni Tapas Chaturvedi (Bom Ao Pharmacy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available